Illinois Municipal Retirement Fund Has $9.60 Million Stock Position in DocuSign, Inc. (NASDAQ:DOCU)

Illinois Municipal Retirement Fund lifted its stake in DocuSign, Inc. (NASDAQ:DOCUFree Report) by 103.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 106,695 shares of the company’s stock after purchasing an additional 54,251 shares during the quarter. Illinois Municipal Retirement Fund owned 0.05% of DocuSign worth $9,596,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of DOCU. Creative Planning boosted its position in shares of DocuSign by 5.6% in the 3rd quarter. Creative Planning now owns 14,453 shares of the company’s stock valued at $897,000 after purchasing an additional 766 shares during the period. Blue Trust Inc. boosted its position in shares of DocuSign by 1,355.9% in the 3rd quarter. Blue Trust Inc. now owns 1,485 shares of the company’s stock valued at $92,000 after purchasing an additional 1,383 shares during the period. Raymond James & Associates boosted its position in shares of DocuSign by 16.3% in the 3rd quarter. Raymond James & Associates now owns 166,406 shares of the company’s stock valued at $10,332,000 after purchasing an additional 23,269 shares during the period. International Assets Investment Management LLC boosted its position in shares of DocuSign by 5,660.8% in the 3rd quarter. International Assets Investment Management LLC now owns 438,914 shares of the company’s stock valued at $27,252,000 after purchasing an additional 431,295 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. boosted its position in shares of DocuSign by 13.5% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 3,466 shares of the company’s stock valued at $214,000 after purchasing an additional 413 shares during the period. Institutional investors and hedge funds own 77.64% of the company’s stock.

DocuSign Price Performance

Shares of DocuSign stock opened at $81.69 on Wednesday. The firm has a market cap of $16.50 billion, a price-to-earnings ratio of 16.84, a P/E/G ratio of 6.94 and a beta of 0.89. DocuSign, Inc. has a 52-week low of $48.70 and a 52-week high of $107.86. The stock has a 50-day simple moving average of $91.12 and a 200-day simple moving average of $77.29.

Insider Activity at DocuSign

In related news, CEO Allan C. Thygesen sold 7,763 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $80.54, for a total value of $625,232.02. Following the transaction, the chief executive officer now directly owns 100,062 shares of the company’s stock, valued at approximately $8,058,993.48. This trade represents a 7.20 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Daniel D. Springer sold 581,588 shares of the firm’s stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $97.04, for a total value of $56,437,299.52. Following the completion of the transaction, the director now directly owns 906,430 shares in the company, valued at $87,959,967.20. The trade was a 39.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 693,773 shares of company stock valued at $66,727,926. Corporate insiders own 1.66% of the company’s stock.

Wall Street Analyst Weigh In

DOCU has been the subject of a number of research reports. Morgan Stanley raised their price objective on DocuSign from $62.00 to $97.00 and gave the stock an “equal weight” rating in a research report on Friday, December 6th. Hsbc Global Res upgraded DocuSign to a “moderate sell” rating in a research report on Friday, December 6th. Royal Bank of Canada restated a “sector perform” rating and set a $90.00 price objective (up from $57.00) on shares of DocuSign in a research report on Friday, December 6th. JPMorgan Chase & Co. raised their price objective on DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a research report on Tuesday, December 3rd. Finally, Needham & Company LLC restated a “hold” rating on shares of DocuSign in a research report on Tuesday, February 4th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $92.45.

View Our Latest Stock Report on DOCU

DocuSign Company Profile

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Featured Stories

Institutional Ownership by Quarter for DocuSign (NASDAQ:DOCU)

Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.